Researchers found that COVID-19 can reactivate dormant viruses in the body, including Epstein-Barr and cytomegalovirus. A study from Boston Children’s Hospital revealed that one particular family of viruses, Anelloviridae, is linked to long COVID and ongoing disability. This connection could help explain why some people struggle to recover after their initial COVID-19 infection.

Understanding how these dormant viruses reactivate is crucial for anyone looking to age well and maintain their health. Up to 10 million adults in the U.S. may experience long COVID, which can lead to chronic fatigue, muscle weakness, and cognitive issues. The study tracked 1,154 hospitalized patients and found that reactivation of Anelloviridae was significantly associated with long-term physical disability, highlighting the importance of monitoring viral activity during and after COVID-19.

The research, which is part of a larger effort funded by the National Institutes of Health, is still in its early stages. It involved comprehensive genomic sequencing and biomarker analysis but has yet to lead to definitive treatment strategies. While the findings are promising, they underscore the need for further investigation into how reactivated viruses might impact recovery from COVID-19 and overall health.

As researchers continue to explore these connections, it may be beneficial for individuals to monitor their health closely after a COVID-19 infection, especially if they experience lingering symptoms. Staying informed about potential viral reactivation could be a step toward better management of long COVID and related health issues. For more details, you can read the full findings in the Nature study.